These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6374030)

  • 1. Human serum bactericidal activity against Haemophilus influenzae type b.
    Stull TL; Jacobs RF; Haas JE; Roberts MC; Wilson CB; Smith AL
    J Gen Microbiol; 1984 Mar; 130(3):665-72. PubMed ID: 6374030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naturally occurring bactericidal antibodies specific for Haemophilus influenzae lipooligosaccharide are present in healthy adult individuals.
    Choi J; Nix EB; Gaultier GN; Cox AD; McCready W; Ulanova M
    Vaccine; 2015 Apr; 33(16):1941-7. PubMed ID: 25738817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins.
    Gnehm HE; Pelton SI; Gulati S; Rice PA
    J Clin Invest; 1985 May; 75(5):1645-58. PubMed ID: 3873475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opsonization and phagocytosis of Haemophilus influenzae type B organisms by mouse polymorphonuclear leucocytes and antiribosomal serum.
    Katz MA; Solotorovsky M; Lynn M
    Br J Exp Pathol; 1983 Jun; 64(3):268-76. PubMed ID: 6603862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human serum activities against Hemophilus influenzae, type b.
    Anderson P; Johnston RB; Smith DH
    J Clin Invest; 1972 Jan; 51(1):31-8. PubMed ID: 4536614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against non-typable Haemophilus influenzae following sensitization of gut associated lymphoid tissue: role of specific antibody and phagocytes.
    Wallace FJ; Witt CS; Clancy RL; Cripps AW
    Immunol Cell Biol; 1995 Jun; 73(3):258-65. PubMed ID: 7590900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae.
    Musher DM; Hague-Park M; Baughn RE; Wallace RJ; Cowley B
    Infect Immun; 1983 Jan; 39(1):297-304. PubMed ID: 6600447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination.
    Musher D; Goree A; Murphy T; Chapman A; Zahradnik J; Apicella M; Baughn R
    J Infect Dis; 1986 Dec; 154(6):935-43. PubMed ID: 3491165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separation of serum bactericidal and opsonizing activities for Haemophilus influenzae type b.
    Newman SL; Waldo B; Johnston RB
    Infect Immun; 1973 Sep; 8(3):488-90. PubMed ID: 4542337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target antigens for bactericidal and opsonizing antibodies to Haemophilus influenzae.
    Dahlberg-Lagergård T
    Acta Pathol Microbiol Immunol Scand C; 1982 Aug; 90(4):209-16. PubMed ID: 6982592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bactericidal activity against Haemophilus influenzae.
    Gordon DL
    Pathology; 1988 Apr; 20(2):124-9. PubMed ID: 3264903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological and biological activities of anti-Haemophilus influenzae ribosomal serum.
    Katz M; Lynn M; Solotorovsky M
    Infect Immun; 1981 Mar; 31(3):1125-31. PubMed ID: 6971811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential complement resistance mediates virulence of Haemophilus influenzae type b.
    Sutton A; Schneerson R; Kendall-Morris S; Robbins JB
    Infect Immun; 1982 Jan; 35(1):95-104. PubMed ID: 6976328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of phenotypic variants of Haemophilus influenzae type b to serum bactericidal activity: relation to surface lipopolysaccharide.
    Gilsdorf JR; Ferrieri P
    J Infect Dis; 1986 Feb; 153(2):223-31. PubMed ID: 3484771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The requirement of specific anticapsular IgG for killing of Haemophilus influenzae by the alternative pathway of complement activation.
    Tarr PI; Hosea SW; Brown EJ; Schneerson R; Sutton A; Frank MM
    J Immunol; 1982 Apr; 128(4):1772-5. PubMed ID: 6977569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity.
    Shaw S; Smith AL; Anderson P; Smith DH
    J Clin Invest; 1976 Oct; 58(4):1019-29. PubMed ID: 1085778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity to Haemophilus influenzae type B: the nature of the bactericidal antibody in human blood.
    Mpairwe Y
    J Med Microbiol; 1971 Feb; 4(1):43-9. PubMed ID: 5313418
    [No Abstract]   [Full Text] [Related]  

  • 19. Bactericidal antibody response against P6, protein D, and OMP26 of nontypeable Haemophilus influenzae after acute otitis media in otitis-prone children.
    Khan MN; Kaur R; Pichichero ME
    FEMS Immunol Med Microbiol; 2012 Aug; 65(3):439-47. PubMed ID: 22463053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of serum-factor induced resistance to somatic antibodies on the virulence of Haemophilus influenzae type b.
    Rubin LG; Moxon ER
    J Gen Microbiol; 1985 Mar; 131(3):515-20. PubMed ID: 3874928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.